Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?

Clinical endocrinology - 1 Mar 2009

Erlic Zoran, Neumann Hartmut P H

Abstract excerpt

About 30% of phaeochromocytoma and paraganglioma patients harbour a germline mutation in one of the known susceptibility genes and in more than one-third of these patients there is no family history for these tumours. The genetic classification, risk assessment and specific management of the patients and at risk family members play an important role in preventive medicine. Distinct diagnostic or therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Genetic Testing
Share to Germ-Line Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Paraganglioma

Share to Pheochromocytoma

Share to Proto-Oncogene Proteins c-ret

Share to Succinate Dehydrogenase

Share to Von Hippel-Lindau Tumor Suppressor Protein

Source

Identifiers

PMID: 19067729
DOI: 10.1111/j.1365-2265.2008.03480.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?PMID 19067729Read ↗

[Genetic diagnosis of phaeochromocytomas and paragangliomas].Semantic proximity Read ↗

The clinical genetics of phaeochromocytoma and paragangliomaSemantic proximity Read ↗

Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.Semantic proximity Read ↗

Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic TestingSemantic proximity Read ↗

Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Paraganglioma and phaeochromocytoma: from genetics to personalized medicineSemantic proximity Read ↗

Pheochromocytoma: When to search a germline defect?Semantic proximity Read ↗

Familial pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Genetics of pheochromocytomas and paragangliomasSemantic proximity Read ↗

Genetic bases of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.Semantic proximity Read ↗

Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.